Cargando…

Novel combined endoscopic and laparoscopic surgery for advanced T2 gastric cancer: Two case reports

BACKGROUND: The standard treatment for advanced T2 gastric cancer (GC) is laparoscopic or surgical gastrectomy (either partial or total) and D2 lymphadenectomy. A novel combined endoscopic and laparoscopic surgery (NCELS) has recently been proposed as a better option for T2 GC. Here we describe two...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jian-Hua, Qian, Feng, Chen, Lei, Xu, Sen-Lin, Feng, Xiao-Feng, Wu, Hong-Bo, Chen, Yao, Peng, Zhi-Hong, Yu, Pei-Wu, Peng, Gui-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044963/
https://www.ncbi.nlm.nih.gov/pubmed/36998943
http://dx.doi.org/10.12998/wjcc.v11.i9.2029
Descripción
Sumario:BACKGROUND: The standard treatment for advanced T2 gastric cancer (GC) is laparoscopic or surgical gastrectomy (either partial or total) and D2 lymphadenectomy. A novel combined endoscopic and laparoscopic surgery (NCELS) has recently been proposed as a better option for T2 GC. Here we describe two case studies demonstrating the efficacy and safety of NCELS. CASE SUMMARY: Two T2 GC cases were both resected by endoscopic submucosal dissection and full-thickness resection and laparoscopic lymph nodes dissection. This method has the advantage of being more precise and minimally invasive compared to current methods. The treatment of these 2 patients was safe and effective with no complications. These cases were followed up for nearly 4 years without recurrence or metastasis. CONCLUSION: This novel method provides a minimally invasive treatment option for T2 GC, and its potential indications, effectiveness and safety needs to be further evaluated in controlled studies.